Marco E. Bianchi
- Clinical Biochemistry top 0.01%
- Advanced Glycation End Products research 91
- Immunology top 0.05%
- Immune Response and Inflammation 50
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 22
- Neurology top 0.2%
- Molecular Biology top 0.2%
- Genomics and Chromatin Dynamics 30
- RNA Research and Splicing 20
- RNA and protein synthesis mechanisms 19
- S100 Proteins and Annexins 18
- Cancer Research top 0.5%
- NF-κB Signaling Pathways 22
- Co-authors
- Paola ScaffidiTom MisteliAngelo A. ManfrediA AgrestiMônica BeltrameEmilie VénéreauPatrizia Rovere‐QueriniSusanne Müller
- Journals
- The EMBO Journal (11 papers)Frontiers in Immunology (9 papers)Journal of Leukocyte Biology (8 papers)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Marco E. Bianchi
221 papers receiving 30.6k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Clinical Biochemistry 11.2k
- Immunology 11.6k
- Neurology 2.2k
- Molecular Biology 13.2k
- Cancer Research 2.0k
Countries citing papers authored by Marco E. Bianchi
This map shows the geographic impact of Marco E. Bianchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco E. Bianchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco E. Bianchi more than expected).
Fields of papers citing papers by Marco E. Bianchi
This network shows the impact of papers produced by Marco E. Bianchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco E. Bianchi. The network helps show where Marco E. Bianchi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marco E. Bianchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 20 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2021 | 23 | |
| 5 | 2020 | 31 | |
| 6 | 2019 | 36 | |
| 7 | 2018 | 175 | |
| 8 | 2018 | 61 | |
| 9 | 2012 | 199 | |
| 10 | Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine releasebreakdown → | 2012 | 561 |
| 11 | 2011 | 21 | |
| 12 | Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizuresbreakdown → | 2010 | 726 |
| 13 | 2010 | 3 | |
| 14 | 2009 | 153 | |
| 15 | 2008 | 431 | |
| 16 | 2005 | 442 | |
| 17 | 2001 | 99 | |
| 18 | 2000 | 7 | |
| 19 | 1999 | 56 | |
| 20 | DNA--protein interactions. Applying a genetic cantilever. | 1995 | 1 |
About Marco E. Bianchi
Marco E. Bianchi is a scholar working on Clinical Biochemistry, Immunology, Cancer Research, Molecular Biology and Immunology and Allergy, having authored 225 papers that have together received 31.0k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (91 papers), Immune Response and Inflammation (50 papers), Genomics and Chromatin Dynamics (30 papers), NF-κB Signaling Pathways (22 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (22 papers), RNA Research and Splicing (20 papers), RNA and protein synthesis mechanisms (19 papers) and S100 Proteins and Annexins (18 papers). The work is most often cited by research in Clinical Biochemistry (11.2k citations), Immunology (11.6k citations), Neurology (2.2k citations), Molecular Biology (13.2k citations) and Cancer Research (2.0k citations). Marco E. Bianchi has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Paola Scaffidi, Tom Misteli, Angelo A. Manfredi, A Agresti, Mônica Beltrame, Emilie Vénéreau, Patrizia Rovere‐Querini, Susanne Müller, Lorenza Ronfani and Francesco De Marchis. Their work appears in journals such as The EMBO Journal, Frontiers in Immunology, Journal of Leukocyte Biology, Journal of Biological Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.